The effect of apoptotic endonuclease EndoG on alternative splicing of mRNA of human telomerase catalytic subunit hTERT (human telomerase reverse transcriptase) and telomerase activity in normal human lymphocytes were studied. Human CD4+, CD8+, B, and NK cells were transfected with a plasmid pEndoG-GFP containing EndoG gene or control plasmid pGFP. The levels of mRNA of EndoG or hTERT splicing variants were analyzed by real-time PCR. Protein content was assessed by Western blotting. Telomerase activity was measured by the telomere repeats amplification protocol. EndoG overexpression reduced the expression of active full-length hTERT and increased the expression of inactive splice variant. Shifted balance of hTERT splice variants in cells led to a significant decrease in telomerase activity within 72 h after transfection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blackburn EH. Telomere states and cell fates. Nature. 2000; 408:53-56.
Diener T, Neuhaus M, Koziel R, Micutkova L, Jansen-Dürr P. Role of endonuclease G in senescence-associated cell death of human endothelial cells. Exp. Gerontol. 2010;45(7-8):638-644.
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011-2015.
Listerman I, Sun J, Gazzaniga FS, Lukas JL, Blackburn EH. The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis. Cancer Res. 2013;73:2817-2828.
Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 1997;90(4):785-795.
Saebøe-Larssen S, Fossberg E, Gaudernack G. Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues. BMC Mol. Biol. 2006;7:26.
Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 1998;58(18):4168-4172.
Ulaner GA, Hu JF, Vu TH, Oruganti H, Giudice LC, Hoffman AR. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int. J. Cancer. 2000;85(3):330-335.
Vasina DA, Zhdanov DD, Orlova EV, Orlova VS, Pokrovskaya MV, Aleksandrova SS, Sokolov NN. Apoptotic Endonuclease EndoG inhibits telomerase activity and induces malignant transformation of human CD4+ T cells. Biochemistry (Mosc.). 2017;82(1):24-37.
Zhdanov DD, Vasina DA, Orlova VS, Gotovtseva VY, Bibikova MV, Pokrovsky VS, Pokrovskaya MV, Aleksandrova SS, Sokolov NN. Apoptotic endonuclease EndoG induces alternative splicing of telomerase catalytic subunit hTERT and death of tumor cells. Biomed. Khim. 2016;62(3):239-250.
Zhdanov DD, Vasina DА, Orlova EV, Orlova VS, Pokrovsky VS, Pokrovskaya MV, Aleksandrova SS, Sokolov NN. Cisplatin-induced apoptotic endonuclease EndoG inhibits telomerase activity and causes malignant transformation of human CD4+ T lymphocytes. Biomed. Khim. 2017;63(1):13-26.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 164, No. 10, pp. 479-483, October, 2017
Rights and permissions
About this article
Cite this article
Zhdanov, D.D., Gladilina, Y.A., Pokrovskaya, M.V. et al. Induction of Alternative Splicing and Inhibition of Activity of Telomerase Catalytic Subunit by Apoptotic Endonuclease EndoG in Human T, B, and NK Cells. Bull Exp Biol Med 164, 478–482 (2018). https://doi.org/10.1007/s10517-018-4016-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-018-4016-y